2013
DOI: 10.1289/ehp.1205740
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Biomonitoring Data from the CDC National Exposure Report in a Risk Assessment Context: Perspectives across Chemicals

Abstract: Background: Biomonitoring data reported in the National Report on Human Exposure to Environmental Chemicals [NER; Centers for Disease Control and Prevention (2012)] provide information on the presence and concentrations of > 400 chemicals in human blood and urine. Biomonitoring Equivalents (BEs) and other risk assessment–based values now allow interpretation of these biomonitoring data in a public health risk context.Objectives: We compared the measured biomarker concentrations in the NER with BEs and similar … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
68
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 143 publications
(70 citation statements)
references
References 32 publications
(23 reference statements)
1
68
1
Order By: Relevance
“…or POD values from animal experiments (Hays et al, 2007Clewell et al, 2008;Angerer et al, 2011). The HBM data are compared against these reference biomarker concentrations to evaluate health risks and set priorities for risk assessment (Aylward et al, 2013) (i.e., relating internal dose to health effects; Figure 1). Reverse dosimetry on the other hand, aims to estimate the exposure dose that would result in the measured biomarker concentration (i.e., connecting internal dose to exposure; Figure 1).…”
Section: Hbm Data Interpretation Approachesmentioning
confidence: 99%
See 2 more Smart Citations
“…or POD values from animal experiments (Hays et al, 2007Clewell et al, 2008;Angerer et al, 2011). The HBM data are compared against these reference biomarker concentrations to evaluate health risks and set priorities for risk assessment (Aylward et al, 2013) (i.e., relating internal dose to health effects; Figure 1). Reverse dosimetry on the other hand, aims to estimate the exposure dose that would result in the measured biomarker concentration (i.e., connecting internal dose to exposure; Figure 1).…”
Section: Hbm Data Interpretation Approachesmentioning
confidence: 99%
“…This allows for the direct comparison of the biomarker concentration in a relevant biological matrix (e.g., urine) to BE (derived using appropriate PK data for urine) for a given chemical similar to the HQ approach used in traditional risk assessment. The following equation can be used to calculate the HQ for non-cancer end points (Aylward et al, 2013) [Biomarker] HQ BE =…”
Section: Uses Of Bes In Risk Characterisationmentioning
confidence: 99%
See 1 more Smart Citation
“…It was noted that human biomonitoring levels for several hundred chemicals are already available and extensive work has been published on approaches that enable human biomonitoring data to be interpreted in a risk context (Aylward et al, 2013;Wambaugh et al, 2013). Workshop participants noted that the implementation and use of biomonitoring/exposure (i.e., internal dose) could provide greater understanding and a better means to compare the significance of concentrations responsible for exerting effects in vitro with respect to the internal doses that produce responses in in vivo studies.…”
Section: Utilization Of Exposure Informationmentioning
confidence: 99%
“…Application: Soring methods provide a simple risk ranking method that is often implemented to easily characterize chemical hazards for subsequent categorization into particular groups (Aylward et al, 2013;Bietlot and Kolakowski, 2012;Bu et al, 2013;Greim and Reuter, 2001;Taxell et al, 2013;van Asselt et al, 2013). It provides a screening tool that is often implemented as a pre-analysis to understand the potential risk before more in-depth risk assessments are later utilized.…”
mentioning
confidence: 99%